U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H12O5
Molecular Weight 284.2635
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIOCHANIN A

SMILES

COC1=CC=C(C=C1)C2=COC3=C(C2=O)C(O)=CC(O)=C3

InChI

InChIKey=WUADCCWRTIWANL-UHFFFAOYSA-N
InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)12-8-21-14-7-10(17)6-13(18)15(14)16(12)19/h2-8,17-18H,1H3

HIDE SMILES / InChI
Biochanin A, a natural organic compound derived from herbal plants such as peanuts, soy, and red clover, possesses various pharmacological properties including antioxidant and anti-inflammatory. In addition, the compound has anticancer activity, which was shown in the following cells: head and neck squamous cell carcinoma and in osteosarcoma. In both cases, biochanin A induced apoptotic signaling pathway. It has also been found biochanin-A was an inhibitor of fatty acid amide hydrolase.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
2.4 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data.
2015-11-19
Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
2015-03-02
The characterisation of structural and antioxidant properties of isoflavone metal chelates.
2010-10
Biochanin A induction of sulfotransferases in rats.
2010-04-15
Syntheses, characterization and antitumor activities of transition metal complexes with isoflavone.
2010-04
Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications.
2010-02-15
Novel screening method for potential skin-whitening compounds by a luciferase reporter assay.
2010
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids.
2009-03-16
Establishment of a transgenic yeast screening system for estrogenicity and identification of the anti-estrogenic activity of malachite green.
2008-12-15
Isoflavonoid glycosides and rotenoids from Pongamia pinnata leaves.
2008-04-05
NMR spectral assignments of a new [C--O--C] isoflavone dimer from Andira surinamensis.
2008-01
25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone.
2007-02-01
Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
2007-02
Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells.
2006-11
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.
2006-09
Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells.
2006-07
The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity.
2006-06-01
Up-regulation of interleukin-4 production via NF-AT/AP-1 activation in T cells by biochanin A, a phytoestrogen and its metabolites.
2006-05-01
Responsiveness to estradiol-17beta and to phytoestrogens in primary human osteoblasts is modulated differentially by high glucose concentration.
2006-05
The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract.
2006-03
Estrogen-related receptors as emerging targets in cancer and metabolic disorders.
2006
Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action.
2005-12
Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations.
2005-10-15
The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system.
2005-10
Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense).
2005-08-10
Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells.
2005-08
Metabolic engineering of isoflavonoid biosynthesis in alfalfa.
2005-08
25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds.
2005-04-05
Metabolic O-demethylation does not alter the influence of isoflavones on the biophysical properties of membranes and MRP1-like protein transport activity.
2005-01-15
Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover).
2004-10-20
Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors.
2004-02
Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake.
2004-01-09
Natural products for dental caries prevention.
2004
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
2003-11
Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones.
2003-07
Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals.
2003-03
Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
2003
Effect of xenoestrogen exposure on the expression of cytochrome P450 isoforms in rainbow trout liver.
2002-11
Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.
2002-08-01
Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.
2002-07
Cytotoxic activity of low molecular weight polyphenols against human oral tumor cell lines.
2000-08-23
Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids.
1999-11-15
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
1998-10
Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.
1998-02
Inhibition of HIV activation in latently infected cells by flavonoid compounds.
1996-01-01
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Biochanin A inhibited the hydrolysis of 0.5 µM anandamide by mouse, rat and human FAAH with IC50 values of 1.8, 1.4 and 2.4 µM respectively. The compound did not interact to any major extent with CB1 or CB2 receptors, nor with FAAH-2.
Name Type Language
BIOCHANIN A
MI   USP-RS  
Common Name English
NSC-123538
Preferred Name English
BIOCHANIN A [USP-RS]
Common Name English
5,7-DIHYDROXY-4'-METHOXYISOFLAVONE
Common Name English
BIOCHANIN A [MI]
Common Name English
BIOCHANIN
Common Name English
4'-METHYLGENISTEIN
Common Name English
BIOCHANINE A
Common Name English
BIOCHANIN A (CONSTITUENT OF RED CLOVER) [DSC]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C599
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
DSLD 249 (Number of products:1)
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
Code System Code Type Description
FDA UNII
U13J6U390T
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
PUBCHEM
5280373
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
DRUG BANK
DB15334
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
MESH
C004541
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
NSC
123538
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-744-7
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
CHEBI
58194
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
NCI_THESAURUS
C28201
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
WIKIPEDIA
BIOCHANIN A
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
CAS
491-80-5
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
CHEBI
17574
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
RS_ITEM_NUM
1071381
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID1022394
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY
MERCK INDEX
m2501
Created by admin on Mon Mar 31 18:52:26 GMT 2025 , Edited by admin on Mon Mar 31 18:52:26 GMT 2025
PRIMARY Merck Index